Caribou Biosciences
CRBU
133 hedge funds and large institutions have $93.1M invested in Caribou Biosciences in 2024 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 48 increasing their positions, 27 reducing their positions, and 22 closing their positions.
78% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 27
36% more call options, than puts
Call options by funds: $240K | Put options by funds: $176K
23% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 22
6.39% more ownership
Funds ownership: 57.96% → 64.35% (+6.4%)
3% more funds holding
Funds holding: 129 → 133 (+4)
10% less capital invested
Capital invested by funds: $103M → $93.1M (-$10M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$4.15M |
| 2 |
Morgan Stanley
New York
|
+$3.12M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$2.43M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$941K |
| 5 |
Two Sigma Advisers
New York
|
+$838K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$5.63M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.22M |
| 3 |
BlackRock
New York
|
-$1.35M |
| 4 |
Renaissance Technologies
New York
|
-$1.16M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$865K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CPA
151
Capital Performance Advisors
Walnut Creek,
California
| – | -$1.32K | -675 | Closed |
|
|
JPWM
152
Jamison Private Wealth Management
Milton,
Georgia
| – | -$369 | -188 | Closed |
|
153
Comerica Bank
Dallas,
Texas
| – | -$249 | -127 | Closed |
|
CRBU Hedge Fund Activity: Q4 2024 in Review
133 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Caribou Biosciences (CRBU) for Q4 2024, worth a combined $93.1M — down 9.7% from $103M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new CRBU positions and 22 closed out — a net gain of 5 holders — while 48 added to existing stakes and 27 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $4.15M. The largest seller was Bank of America, cutting an estimated $5.63M.
- 133 institutional investors held Caribou Biosciences (CRBU) as of Q4 2024, up from 129 in Q3 2024.
- Funds reported $93.1M of Caribou Biosciences stock for Q4 2024, down 9.7% quarter-over-quarter.
- 27 funds opened new Caribou Biosciences positions in Q4 2024 and 22 closed out, a net change of +5 holders.
- The largest Caribou Biosciences buyer in Q4 2024 was JP Morgan Chase, an estimated $4.15M added.
- The largest Caribou Biosciences seller in Q4 2024 was Bank of America, an estimated $5.63M sold.
Based on aggregated 13F filings for Q4 2024.